1997 – 3C Pharma Founded
3C Pharma is founded, with Schering Plough as its first major client, marking the beginning of a journey in providing innovative technological solutions to the pharmaceutical industry.
3C Pharma is founded, with Schering Plough as its first major client, marking the beginning of a journey in providing innovative technological solutions to the pharmaceutical industry.
3C Pharma designs and implements a proprietary Clinical Trial Management System (CTMS) with eight regional hubs, revolutionizing the way global clinical trials are managed.
3C Pharma introduces PharmaPay in France, a groundbreaking platform to manage clinical trial payments, streamlining financial operations for the life sciences industry.
PharmaPay expands globally, now integrated with CTMS for patient treatment schedules and clinical trial forecasting, improving financial transparency and efficiency.
3C Pharma pioneers the use of Digital Pen technology to collect trial data in agricultural studies, bringing innovation to the agricultural sector.
3C Pharma implements Digital Pen technology for Patient Reported Outcomes (ePRO), leading the way in digitizing patient data collection for clinical trials
The myPROpad iPad solution is launched, allowing the collection of Patient Reported Outcomes (ePRO) in clinical trials for prestigious institutions such as Rutgers and Yale.
3C Pharma develops custom software to implement KPMG’s Ringfencing strategy for Novartis, enhancing regulatory and financial compliance.
myPROpad is enhanced for specialized octogenarian clinical trials, improving usability for elderly patients in complex studies.
myPROpad replaces PHT in a highly complex clinical trial, addressing patient objections and improving the overall trial experience.
myPROpad is chosen for multiple Merck global clinical trials, leveraging its multi-lingual capabilities to support diverse patient populations worldwide.
3C Pharma is recognized by Merck for going “above and beyond” to quickly implement Virtual Visits in ongoing clinical trials during the COVID-19 pandemic, ensuring trial continuity.
3C Pharma architects a groundbreaking Veeva implementation for Medical Affairs, integrating with four commercial systems globally—a first for Veeva—enhancing cross-functional operations for pharmaceutical companies..